Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Osteoporosis International · 2025-04 · 36 (4) · 579-608
DOI: 10.1007/s00198-025-07422-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Osteoporosis International, online erschienen am 28.03.2025. Verfasst von Harjit Pal Bhattoa und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Blvd. 98, 4032, Debrecen, Hungary. harjit@med.unideb.hu. Hauptthemen laut MEDLINE: Bone Remodeling, Osteoporosis. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 284 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Debrecen.
Abstract (Originalsprache)
PURPOSE: The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) have proposed procollagen type I N propeptide (PINP) and β isomerized C-terminal telopeptide of type I collagen (β-CTX-I) as reference bone turnover markers (BTMs) for osteoporosis. This report examines the published literature since the 2011 IOF-IFCC position paper in order to determine the clinical potential of the reference BTMs and newer markers for the prediction of fracture risk and monitoring the treatment of osteoporosis. METHODS: Evidence for the relationship between BTMs and subsequent fractures was gathered from prospective studies through literature review of the Medline database from years 2011 to May 2024. The impact of treatment on BTMs was also studied by examining publications in that period. Studies of the accuracy of BTMs in the assessment of bone turnover in the setting of advanced chronic kidney disease were also examined. RESULTS: Increased BTM concentrations are associated with higher fracture risk in postmenopausal women. PINP and β-CTX-I measured in blood are associated with fracture risk but their interaction with other risk factors has not been sufficiently studied limiting their incorporation into fracture risk algorithms. Treatment-induced changes in PINP and β-CTX-I account for a substantial proportion of fracture risk reduction and are useful for improving adherence; they are recommended for inclusion in studies to examine adherence in individual patients. However, total PINP (tPINP) and β-CTX-I may be elevated in CKD due to renal retention. Bone alkaline phosphatase (BALP), intact PINP (iPINP), and tartrate resistant acid phosphatase 5b (TRACP5b) show the most promise in discriminating high and low turnover bone diseases in patients with advanced CKD and for predicting fracture risk, monitoring treatment response, and assessing the risk of treatment-related complications. CONCLUSION: We re-affirm the use of serum/plasma tPINP and plasma β-CTX-I as reference BTMs with appropriate patient preparation and sample handling and measurement by standardized/harmonized assays in clinical studies to accumulate further data, and for monitoring treatment of osteoporosis in the setting of normal renal function in clinical practice. BALP and TRACP5b, measured by standardized assays, are recommended as reference BTMs for CKD-associated osteoporosis and should be included in observational and intervention studies to ascertain their utility for risk-evaluation, treatment initiation, and assessment of treatment response in CKD-associated osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Blvd. 98, 4032, Debrecen, Hungary. harjit@med.unideb.hu.
- PathWest Laboratory Medicine WA, Murdoch, WA6150, Australia.
- Clinical Biochemistry Department-KAT General Hospital, Kifissia, Athens, Greece.
- Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, University of Athens, Athens, Greece.
- Clinical Biochemistry Department, General Hospital of Lamia, 35100, Lamia, Greece.
- Laboratory of Experimental Biochemistry, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy.
Förderung
- University of Debrecen
Zitieren
APA
Bhattoa, H. P., Vasikaran, S., Trifonidi, I., Kapoula, G., Lombardi, G., Jørgensen, N. R., Pikner, R., Miura, M., Chapurlat, R., Hiligsmann, M., Haarhaus, M., Evenepoel, P., Jørgensen, H. S., Herrmann, M., Kaufman, J. M., Clark, P., Tuzun, Ş., Al-Daghri, N., Silverman, S., …, & Cavalier, E. (2025). Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporosis International, 36(4), 579-608. https://doi.org/10.1007/s00198-025-07422-3
Vancouver
Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, Lombardi G, Jørgensen NR, et al. Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporosis International. 2025;36(4):579-608. doi:10.1007/s00198-025-07422-3
BibTeX
@article{Bhattoa2025,
author = {Bhattoa, Harjit Pal and Vasikaran, Samuel and Trifonidi, Ioulia and Kapoula, Georgia and Lombardi, Giovanni and Jørgensen, Niklas Rye and Pikner, Richard and Miura, Masakazu and Chapurlat, Roland and Hiligsmann, Mickael and Haarhaus, Mathias and Evenepoel, Pieter and Jørgensen, Hanne Skou and Herrmann, Markus and Kaufman, Jean-Marc and Clark, Patricia and Tuzun, Şansın and Al-Daghri, Nasser and Silverman, Stuart and Alokail, Majed S and Ormarsdóttir, Sif and Yerro, María Concepción Prieto and Matijevic, Radmila and Laslop, Andrea and da Silva Rosa, Mario Miguel Coelho and Zakraoui, Leith and Burlet, Nansa and McCloskey, Eugene and Harvey, Nicholas C and Radermecker, Régis P and Fusaro, Maria and Torre, Carla and Kanis, John A and Rizzoli, René and Reginster, Jean-Yves and Makris, Konstantinos and Cavalier, Etienne},
title = {Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)},
journal = {Osteoporosis International},
year = {2025},
volume = {36},
number = {4},
pages = {579--608},
doi = {10.1007/s00198-025-07422-3}
}
EUVIMED